Loading...
OTCM
IPAH
Market cap273kUSD
Nov 03, Last price  
0.00USD
Name

Interpharm Holdings Inc

Chart & performance

D1W1MN
OTCM:IPAH chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
76m
+19.31%
29,700,00081,800,000100,800,000187,200,000107,400,00071,937,68053,051,12039,032,04341,100,00039,911,00063,355,00075,587,000
Net income
-14m
L+270.92%
-2,300,000800,0001,700,0002,700,000-4,300,000296,953-4,525,134-1,676,4083,123,000-149,000-3,790,000-14,058,000
CFO
-14m
L
-300,000-600,0003,000,000-1,300,000-600,000-1,589,6871,520,027-61,9882,126,000-2,353,000801,000-14,105,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.

Key people

Maganlal K. Sutaria
Chairman of the Board · since 2005
Peter Giallorenzo
Chief Financial Officer, Chief Operating Officer, Executive Vice President · since 2007
Kenneth M Cappel
Executive Vice President, General Counsel · since 2006
Raj M Sutaria
Executive Vice President · since 2007
Stewart H. Benjamin
Director · since 2001
Kennith Johnson
Director · since 2004
Richard J. Miller
Director · since 2006
Joan P. Neuscheler
Director · since 2006
David C. Reback
Director · since 1997
URL
IPO date
Feb 12, 1993
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show